BiocardiaInc Selling General Administrative from 2010 to 2024

BCDA Stock  USD 0.38  0.01  2.70%   
BiocardiaInc's Selling General Administrative is increasing over the years with slightly volatile fluctuation. Selling General Administrative is expected to dwindle to about 3.3 M. From 2010 to 2024 BiocardiaInc Selling General Administrative quarterly data regression line had arithmetic mean of  3,104,978 and r-squared of  0.50. View All Fundamentals
 
Selling General Administrative  
First Reported
1996-09-30
Previous Quarter
1.1 M
Current Value
941 K
Quarterly Volatility
897.6 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BiocardiaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BiocardiaInc main balance sheet or income statement drivers, such as Depreciation And Amortization of 242 K, Interest Expense of 6.6 K or Selling General Administrative of 3.3 M, as well as many exotic indicators such as Price To Sales Ratio of 28.02, Dividend Yield of 0.0158 or Days Sales Outstanding of 45.8. BiocardiaInc financial statements analysis is a perfect complement when working with BiocardiaInc Valuation or Volatility modules.
  
This module can also supplement BiocardiaInc's financial leverage analysis and stock options assessment as well as various BiocardiaInc Technical models . Check out the analysis of BiocardiaInc Correlation against competitors.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.

Latest BiocardiaInc's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of BiocardiaInc over the last few years. It is BiocardiaInc's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BiocardiaInc's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

BiocardiaInc Selling General Administrative Regression Statistics

Arithmetic Mean3,104,978
Geometric Mean1,780,232
Coefficient Of Variation72.55
Mean Deviation1,964,243
Median3,734,000
Standard Deviation2,252,530
Sample Variance5.1T
Range5.8M
R-Value0.71
Mean Square Error2.7T
R-Squared0.50
Significance0
Slope356,914
Total Sum of Squares71T

BiocardiaInc Selling General Administrative History

20243.3 M
20234.4 M
20224.4 M
20215.1 M
20205.9 M
2019M
20185.8 M

About BiocardiaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BiocardiaInc income statement, its balance sheet, and the statement of cash flows. BiocardiaInc investors use historical funamental indicators, such as BiocardiaInc's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although BiocardiaInc investors may use each financial statement separately, they are all related. The changes in BiocardiaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BiocardiaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BiocardiaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BiocardiaInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative4.4 M3.3 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BiocardiaInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BiocardiaInc's short interest history, or implied volatility extrapolated from BiocardiaInc options trading.

Pair Trading with BiocardiaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.

Moving against BiocardiaInc Stock

  0.56ACB Aurora Cannabis Sell-off TrendPairCorr
  0.51CGC Canopy Growth Corp Financial Report 27th of June 2024 PairCorr
  0.47ELYM Eliem Therapeutics Upward RallyPairCorr
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BiocardiaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BiocardiaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardiainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardiainc Stock:
Check out the analysis of BiocardiaInc Correlation against competitors.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for BiocardiaInc Stock analysis

When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.55)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.88)
Return On Assets
(1.14)
Return On Equity
(7.04)
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.